MHC Class II and Beyond: Complex Role of CD74 in Cancer
Cells · 11.01.2026 · 15 (2) · 128
DOI: 10.3390/cells15020128 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 11.01.2026. Verfasst von Joanna Bandola-Simon und 1 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class II, Neoplasms, Antigens, Differentiation, B-Lymphocyte. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural Research Program of the NIH, Intramural Research Program of the National Institutes of Health.
Abstract (Originalsprache)
Invariant chain, also known as CD74 when expressed on the plasma membrane, is classically recognized for its role in Major Histocompatibility Complex class II molecule assembly, trafficking, and peptide loading in professional antigen presenting cells. However, recent studies implicate CD74 as a broader regulator of tumor–immune interactions, modulating antigen presentation, cytokine signaling, and immune evasion across diverse cancers. This review synthesizes emerging evidence that CD74 functions as a “master regulator” of antigen presentation in cancer, integrating its canonical chaperone role with its noncanonical role in transcription regulation and in signaling via macrophage migration inhibitory factor. We explore how tumor microenvironmental contexts redefine CD74 biology, influencing antitumor immunity and therapeutic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Joanna Bandola-Simon, Paul A Roche
Förderung
- Intramural Research Program of the NIH
- Intramural Research Program of the National Institutes of Health
Zitieren
APA
Bandola-Simon, J., & Roche, P. A. (2026). MHC Class II and Beyond: Complex Role of CD74 in Cancer. Cells, 15(2), 128. https://doi.org/10.3390/cells15020128
Vancouver
Bandola-Simon J, Roche PA. MHC Class II and Beyond: Complex Role of CD74 in Cancer. Cells. 2026;15(2):128. doi:10.3390/cells15020128
BibTeX
@article{BandolaSimon2026,
author = {Bandola-Simon, Joanna and Roche, Paul A},
title = {MHC Class II and Beyond: Complex Role of CD74 in Cancer},
journal = {Cells},
year = {2026},
volume = {15},
number = {2},
pages = {128},
doi = {10.3390/cells15020128}
}
EUVIMED